Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010

PLoS Medicine

Volumn 10, Issue 11, 2013, Pages

  Ferrari, Alize J ^a,b   Charlson, Fiona J ^a,b   Norman, Rosana E ^a   Patten, Scott B ^c   Freedman, Greg ^d   Murray, Christopher J L ^d   Vos, Theo ^a,d   Whiteford, Harvey A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Queensland Centre for Mental Health Research   (Australia)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BAYES THEOREM; COMORBIDITY; DISABILITY; DISEASE DURATION; DISEASE SEVERITY; DSM-IV-TR; DYSTHYMIA; GENDER; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; MORTALITY; PREVALENCE; REMISSION; RISK ASSESSMENT; SUICIDE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DEPRESSION; DEPRESSIVE DISORDER; DISABLED PERSONS; FEMALE; HEALTH SURVEYS; HUMANS; INFANT; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SEX FACTORS; SUICIDE; WORLD HEALTH; YOUNG ADULT;

EID: 84889076134     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001547     Document Type: Article

References (45)

1. Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, et al. (2013) Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psycho Med 43: 471-481.
2. Ferrari AJ, Charlson FJ, Norman R, Flaxman AD, Patten SB, et al. (2013) The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS ONE 8: e69637 doi:10.1371/journal.pone.0069637.
3. Charlson FJ, Ferrari AJ, Somerville AJ, Norman R, Patten SB, et al. (2013) The epidemiological modelling of dysthymia: application for the Global Burden of Disease 2010 Study. J Affect Disord 151: 111-120.
4. Murray CJL, Lopez AD, editors (1996) The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (Massachusetts): Harvard School of Public Health on behalf of the World Health Organization & the World Bank.
5. World Health Organization (2008) The Global Burden of Disease: 2004 update. Switzerland. Available: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.
6. Mathers CD, Stein C, Ma Fat D, Rao C, Inoue M, et al. (2002) Global Burden of Disease 2000: version 2 methods and results. Geneva: World Health Organization. Available: http://www.who.int/healthinfo/paper50.pdf.
7. World Bank (1993) World Development Report 1993. Investing in health: world development indicators. New York: World Bank. Available: http://files.dcp2.org/pdf/World Development Report 1993.pdf.
8. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ, (2004) Global burden of depressive disorders in the year 2000. Br J Psychiatry 184: 386-392.
9. Prince M, Patel V, Saxena S, Maj M, Maselko J, et al. (2007) No health without mental health. Lancet 370: 859-877.
10. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). Washington (D.C.): American Psychiatric Association.
11. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.
12. Ayuso-Mateos JL (2000) Global burden of bipolar disorder in the year 2000: version 1. Geneva: World Health Organization. Available: http://www.who.int/healthinfo/statistics/bod_bipolar.pdf.
13. Murray CJL, Ezzati M, Flaxman A, Lim S, Lozano R, et al. (2012) GBD 2010: design, definitions, and metrics. Lancet 380: 2063-2066.
14. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223.
15. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, et al. (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224-2260.
16. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128.
17. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, et al. (2012) Common values in assessing health outcomes from disease and injury:disability weights measurement study for the Global Burden of Disease 2010. Lancet 380: 2129-2143.
18. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2163-2196.
19. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, et al. (2013) The Global Burden of Mental and Substance Use Disorders, 2010. Lancet In press.
20. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 6: e1000097 doi:10.1371/journal.pmed.1000097.
21. Kruijshaar ME, Barendregt J, Vos T, de Graaf R, Spijker J, et al. (2005) Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall bias. Eur J Epidemiol 20: 103-111.
22. Moffitt TE, Caspi A, Taylor AJ, Kokaua J, Milne BJ, et al. (2010) How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psycho Med 40: 899-909.
23. Simon GE, VonKorff M, (1995) Recall of psychiatric history in cross-sectional surveys: implications for epidemiologic research. Epidemiol Rev 17: 221-227.
24. Susser E, Shrout PE, (2010) Two plus two equals three? Do we need to rethink lifetime prevalence? A commentary on 'How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment' by Moffittet al. (2009). Psycho Med 40: 895-897.
25. Baxter AJ, Page A, Whiteford HA, (2011) Factors influencing risk of premature mortality in community cases of depression: a meta-analytic review. Epidemiology Research International 2011: 1-12.
26. Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, et al. (2004) The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatr 61: 1097-1103.
27. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ, (2003) A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr 1: 4.
28. Agency for Healthcare Research and Quality (2012) United States Medical Expenditure Panel Survey 2000-2009. Rockville (Maryland): Agency for Healthcare Research and Quality. Available: http://meps.ahrq.gov/mepsweb/.
29. U.S. National Institutes of Health National Institute on Alcohol Abuse and Alcoholism (2013) National Epidemiologic Survey on Alcohol and Related Conditions Wave 1 and Wave 2. Bethesda (Maryland): National Institutes of Health. Available: http://www.niaaa.nih.gov/.
30. Australian Bureau of Statistics (2008) National Survey of Mental Health and Wellbeing of Adults 1997. Canberra: Australian Bureau of Statistics. Available: http://www.abs.gov.au/AUSSTATS/abs.nsf/allprimarymainfeatures/D5A0AC778746378FCA2574EA00122887?opendocumen.
31. Ware JE, Kosinski M, Keller SD, QualityMetric Incorporated, New England Medical Center Hospital. Health Assessment Lab (2002) SF-12: how to score the SF-12 physical and mental health summary scales. Lincoln (Rhode Island); Boston: QualityMetric Inc, Health Assessment Lab.
32. Baxter AJ, Charlson FJ, Somerville AJ, Whiteford HA, (2011) Mental disorders as risk factors: assessing the evidence for the global burden of disease study. BMC Medicine 9: 1-7.
33. Charlson FJ, Stapelberg NJC, Baxter A, Whiteford HA, (2011) Should Global Burden of Disease estimates include depression as a risk factor for coronary heart disease? BMC Medicine 9: 1-6.
34. Li Z, Page A, Martin G, Taylor R, (2011) Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review. Soc Sci Med 72: 608-616.
35. Eaton WW, Kalaydjian A, Scharfstein D, Mezuk B, Ding Y, (2007) Prevalence and incidence of depressive disorder: the Baltimore ECA follow-up, 1981-2004. Acta Psychiatrica Scandinavica 116: 182-188.
36. Fu TS, Lee CS, Gunnell D, Lee WC, Cheng AT, (2012) Changing trends in the prevalence of common mental disorders in Taiwan: a 20-year repeated cross-sectional survey. Lancet 381: 235-241.
37. Charlson FJ, Steel Z, Degenhardt L, Chey T, Silove D, et al. (2012) Predicting the impact of the 2011 conflict in Libya on population mental health: PTSD and depression prevalence and mental health service requirements. PLoS ONE 7: e40593 doi:10.1371/journal.pone.0040593.
38. GBD 2010 Country Collaboration (2013) GBD 2010 country results: a global public good. Lancet 381: 965-970.
39. Jessop EG, (2013) Health in the UK: could do even better? Lancet 381: 970-972.
40. Murray CJL, Richards MA, Newton JN, Fenton LA, (2013) UK health performance: fi ndings of the Global Burden of Disease Study 2010. Lancet 381: 997-1020.
41. McKnight PE, Kashdan TB, (2009) The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clin Psychol Rev 29: 243-259.
42. Kessler RC, Ustun TB, editors (2008) The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press.
43. Sheehan KH, Sheehan DV, (2008) Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol 23: 70-83.
44. Sheehan DV, Harnett-Sheehan K, Raj BA, (1996) The measurement of disability. Int Clin Psychopharm 11 (Suppl 3) (): 89-95.
45. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, et al. (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105.